Dr. Kurt E. Lund, MD

Dr. Lund practices at Mead Avenue Family Practice, Inc. in Corry, Pennsylvania.

Dr. Lund's NPI, 1578535985, was assigned on February 2, 2006. Dr. Lund graduated from University of South Florida Morsani College of Medicine in 1991. Dr. Lund holds Pennsylvania license MD050434L.

Dr. Lund's primary practice is Mead Avenue Family Practice, Inc., at 1086 Mead Ave, Corry, PA 16407-8503. The practice phone is (814) 664-4542.

Dr. Lund's primary practice is Mead Avenue Family Practice, Inc. in Corry, Pennsylvania. Dr. Lund is also affiliated with LECOM Health Corry Memorial Hospital. The medical group on file is UPMC Hamot. Dmand AI also links Dr. Lund to 3 more hospitals, 2 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lund practices, 9 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Lund's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Lund is licensed in Pennsylvania.

CMS data shows 790 Medicare services from Dr. Lund across 13 procedure codes in 2024, for 174 Medicare patients. Medicare paid $55,709 for them. Every service was in an office.

CMS counts 174 Medicare patients who saw Dr. Lund in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lund's median patient age at 64, with 51% women.

In 2024, Dr. Lund wrote 11,917 Medicare Part D claims for 509 patients. 84% of them were for generic drugs. CMS names the drug for 11,145 of them, across 164 drugs with 11 or more claims each, at $1,282,419 in total drug cost. In 2023, CMS named 11,459 claims across 167 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Lund for performance year 2024, reported through an alternative payment model (APM). Dr. Lund accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lund as offering telehealth. CMS counts 29 procedures of removal of skin lesions by Dr. Lund, more than 68% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 81 general payments to Dr. Lund from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Novo Nordisk Inc paid the most, $289.

Dr. Lund graduated from University of South Florida Morsani College of Medicine in 1991.